Peripheral blood count abnormalities among patients with hepatitis C in the United States

被引:51
|
作者
Streiff, MB
Mehta, S
Thomas, DL
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/jhep.2002.32486
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An estimated 2.7 million people in the United States are infected with the hepatitis C virus (HCV), yet the influence of HCV infection on the peripheral blood count remains unknown. To investigate the prevalence of low peripheral blood counts among HCV-infected adults in the United States general population, we analyzed data collected in the third National Health and Nutrition Examination Survey (NHANES III). The study population consisted of 16,196 individuals age 18 or older who had peripheral blood counts and data on HCV infection. The lowest fifth percentile of each component of the peripheral blood was design nated a priori as being low. HCV infection was assessed by antibody reactivity. HCV antibody-positive individuals were 3-fold more likely to have low neutrophil counts (HCV positive, 9% vs. HCV negative, 3%, P <.0001) and 2.6-fold more likely to have low platelet counts (HCV positive, 13% vs. HCV negative, 5%, P <.0001) independent of other evaluated factors. HCV infection was observed in more than 20% of persons with neutrophil counts below 1.0 X 10(9)/L or platelet counts less than 100 X 10(9)/L. No association was detected between anti-HCV status and anemia or other peripheral blood cell components. In conclusion, HCV-infected persons in the general population of the United States are more likely to have low neutrophil and platelet counts, and HCV testing should be considered for persons with unexplained neutrophil counts below 1.0 X 10(9)/L or platelet counts less than 100 X 10(9)/L. Alternate causes of anemia should be considered for HCV-infected persons with low red blood cell counts.
引用
收藏
页码:947 / 952
页数:6
相关论文
共 50 条
  • [21] PREDICTORS OF MORTALITY AMONG UNITED STATES VETERANS WITH HEPATITIS C VIRUS INFECTION
    Erqou, S.
    Mohanty, A.
    Butt, A. A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S185 - S185
  • [22] CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020
    Schillie, Sarah
    Wester, Carolyn
    Osborne, Melissa
    Wesolowski, Laura
    Ryerson, A. Blythe
    MMWR RECOMMENDATIONS AND REPORTS, 2020, 69 (02): : 1 - 17
  • [23] Economic Burden And Outcomes Of Patients Hospitalized With Hepatitis C In The United States
    Luo, Ruihong
    Stone, Christian D.
    HEPATOLOGY, 2013, 58 : 1289A - 1289A
  • [24] Comorbidities in hepatitis C patients in a United States medical claims database
    Louie, KS
    Theodore, D
    Pimenta, JM
    HEPATOLOGY, 2005, 42 (04) : 753A - 754A
  • [25] Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C
    Tran, A
    Yang, G
    Doglio, A
    Ticchioni, M
    Laffont, C
    Durant, J
    Bernard, JL
    Gugenheim, J
    Saint-Paul, MC
    Bernard, A
    Rampal, P
    Benzaken, S
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (12) : 2495 - 2500
  • [26] Phenotyping of Intrahepatic and Peripheral Blood Lymphocytes in Patients with Chronic Hepatitis C
    Jean-Louis Bernard
    Jean Gugenheim
    Marie-Christine Saint-Paul
    Albert Tran
    Guang Yang
    Alain Doglio
    Michel Ticchioni
    Catherine Laffont
    Jacques Durant
    Alain Bernard
    Patrick Rampal
    Sylvia Benzaken
    Digestive Diseases and Sciences, 1997, 42 : 2495 - 2500
  • [27] Recent and occult hepatitis B virus infections among blood donors in the United States
    Ramachandran, Sumathi
    Groves, Jamel A.
    Xia, Guo-liang
    Saa, Paula
    Notari, Edward P.
    Drobeniuc, Jan
    Poe, Amanda
    Khudyakov, Natasha
    Schillie, Sarah F.
    Murphy, Trudy, V
    Kamili, Saleem
    Teo, Chong-Gee
    Dodd, Roger Y.
    Khudyakov, Yury E.
    Stramer, Susan L.
    TRANSFUSION, 2019, 59 (02) : 601 - 611
  • [28] Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States
    Hassan, MM
    Frome, A
    Patt, YZ
    El-Serag, HB
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (03) : 266 - 269
  • [29] MEDICATION ADHERENCE TO DIRECT ACTING ANTIVIRAL AGENTS AMONG HEPATITIS C VIRUS INFECTED PATIENTS IN THE UNITED STATES
    Khalid, J.
    Li, J.
    Aparasu, R. R.
    VALUE IN HEALTH, 2024, 27 (06) : S340 - S341
  • [30] Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States
    Li, J.
    Zhang, T.
    Gordon, S. C.
    Rupp, L. B.
    Trudeau, S.
    Holmberg, S. D.
    Moorman, A. C.
    Spradling, P. R.
    Teshale, E. H.
    Boscarino, J. A.
    Schmidt, M. A.
    Daida, Y. G.
    Lu, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 952 - 958